H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours
Diego Dibitetto(Cornell University), Sven Rottenberg(University of Bern)
Cited by 40
Related Papers
Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents
|Molecular Oncology|2018|27
PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair
|The EMBO Journal|2024|23
MDC1 counteracts restrained replication fork restart and its loss causes chemoresistance in BRCA1/2-deficient mammary tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|6
Fork Slowing and Reversal as an Adaptive Response to Chronic ATR Inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2